Related Experiment Video
Updated: Aug 14, 2026

Postproduction Processing of Electrospun Fibres for Tissue Engineering
Published on: August 9, 2012
Electrospun Fiber Membranes Modified with Heparin and Parathyroid Hormone Derivative To Promote Diabetic Wound
Xinxin Wu1, Zhuowen Hao1, Zepu Wang1
1Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Abstract:
The repair of diabetic wounds is a global challenge due to elevated levels of blood sugar and microvascular disorders. Parathyroid hormone (PTH) and its derivatives show great potential for wound healing, but corresponding delivery strategies are still limited. Herein, a novel electrospun fiber membrane whose surface is modified with heparin is fabricated to deliver a PTH derivative named parathyroid hormone related peptide-1 (PTHrP-1) for the healing of diabetic wounds. Cell viability, proliferation, migration, and proangiogenic activity are first evaluated in vitro, and then a rat diabetic skin defect model is used to observe the in vivo effects on wound healing. Results of in vitro and in vivo studies confirm that electrospun fiber membrane modified with heparin and PTHrP-1 promotes the proliferation and migration of endothelial cells and fibroblasts, and facilitates diabetic wound healing through angiogenesis, collagen deposition, and re-epithelialization. In conclusion, electrospun fiber membrane modified with heparin shows great promise in delivering PTHrP-1 and promoting diabetic wound healing.
More Related Videos
08:06Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model
Published on: August 4, 2017
06:45Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems
Published on: May 2, 2025
Related Concept Videos
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Dipeptidyl Peptidase 4 Inhibitors
Diabetic Retinopathy
Diabetic Nephropathy
Diabetic Neuropathy
Chronic Pancreatitis II: Pathophysiology